CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Kubota Pharmaceutical Holdings Co Ltd  (AUCL)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 

Kubota Pharmaceutical Holdings Co Ltd's Quick Ratio

AUCL's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:                        

AUCL Quick Ratio (Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter
(Jun 30 2016)
II. Quarter
(Mar 31 2016)
I. Quarter
(Dec 31 2015)
IV. Quarter
Y / Y Current Liabilities Change -60.2 % -35.48 % -25.83 % -49.45 % -33 %
Y / Y Cash & cash equivalent Change 2.14 % 12.9 % 32.05 % 9.96 % 7.92 %
Quick Ratio MRQ 34.17 26.52 20.17 18.4 13.32
Overall Ranking # 76 # 98 # # 148 # 179
Seq. Current Liabilities Change -27.42 % -23.99 % -9.92 % -19.91 % 17.65 %
Seq. Cash & cash equivalent Change -6.46 % -0.07 % -1.25 % 10.65 % 3.39 %



Quick Ratio first quarter 2017 Comment
Current Liabilities decreased faster than Kubota Pharmaceutical Holdings Co Ltd's Cash & cash equivalent, this led to improvement in Kubota Pharmaceutical Holdings Co Ltd's Quick Ratio to 34.17, Quick Ratio remained below Kubota Pharmaceutical Holdings Co Ltd average.

Within Biotechnology & Drugs industry 3 other companies have achieved higher Quick Ratio than Kubota Pharmaceutical Holdings Co Ltd in first quarter 2017. While Quick Ratio total ranking has improved so far to 76, from total ranking in previous quarter at 98.

Explain Quick Ratio?
What are AUCL Segments?
See Quick Ratio AUCL on the trailing twelve month basis
Quick Ratio first quarter 2017 Company Ranking
Within: No.
Industry # 4
Sector # 8
S&P 500 # 76


Quick Ratio Statistics
High Average Low
34.17 15.59 8.27
(Mar 31 2017)   (Dec 31 2014)


You need to upgrade your Flash Player


Financial Statements
Kubota Pharmaceutical Holdings Co Ltd's Current Liabilities $ 3 Millions Visit AUCL's Balance sheet
Kubota Pharmaceutical Holdings Co Ltd's Cash & cash equivalent $ 114 Millions Visit AUCL's Balance sheet
Source of AUCL's Sales Visit AUCL's Sales by Geography




Companies with similar Quick Ratio in the quarter endingMar 31 2017, within Biotechnology & Drugs Industry Quick RatioMar 31 2017 MRQ Cash & cash equivalentMar 31 2017 MRQ Current Liabilities
Adverum Biotechnologies, Inc.  39.26 $ 209.503  Millions$ 5.336  Millions
Regenxbio Inc.  35.31 $ 145.809  Millions$ 4.129  Millions
Kubota Pharmaceutical Holdings Co Ltd  34.17 $ 114.410  Millions$ 3.348  Millions
Gtx Inc  32.12 $ 16.511  Millions$ 0.514  Millions
Atara Biotherapeutics, Inc.  29.58 $ 230.840  Millions$ 7.805  Millions
La Jolla Pharmaceutical Co  28.62 $ 162.382  Millions$ 5.673  Millions
Lion Biotechnologies, Inc.  26.75 $ 147.197  Millions$ 5.503  Millions
Enzon Pharmaceuticals, Inc.  25.09 $ 8.079  Millions$ 0.322  Millions
Obalon Therapeutics Inc  19.01 $ 66.720  Millions$ 3.509  Millions
Crispr Therapeutics Ag  17.08 $ 288.872  Millions$ 16.915  Millions
Cellular Biomedicine Group, Inc.  16.64 $ 33.362  Millions$ 2.006  Millions
Aerie Pharmaceuticals Inc  15.33 $ 207.864  Millions$ 13.562  Millions
Pulse Biosciences, Inc.  15.19 $ 18.860  Millions$ 1.242  Millions
Cadus Corp  14.87 $ 5.122  Millions$ 0.344  Millions
Voyager Therapeutics, Inc.  14.25 $ 157.670  Millions$ 11.064  Millions
Edge Therapeutics, Inc.  14.17 $ 95.591  Millions$ 6.746  Millions
Nantkwest, Inc.  13.45 $ 190.970  Millions$ 14.201  Millions
Cidara Therapeutics, Inc.  13.08 $ 90.086  Millions$ 6.886  Millions
Idera Pharmaceuticals, Inc.  13.02 $ 91.262  Millions$ 7.007  Millions
Asterias Biotherapeutics, Inc.  12.54 $ 32.500  Millions$ 2.592  Millions
Eiger Biopharmaceuticals, Inc.  11.97 $ 49.024  Millions$ 4.097  Millions
Protokinetix, Inc.  11.86 $ 0.549  Millions$ 0.046  Millions
Anavex Life Sciences Corp.  11.48 $ 23.352  Millions$ 2.034  Millions
Proteon Therapeutics Inc  11.29 $ 34.132  Millions$ 3.023  Millions
Cohbar, Inc.  11.06 $ 9.190  Millions$ 0.831  Millions
Brainstorm Cell Therapeutics Inc.  10.58 $ 8.347  Millions$ 0.789  Millions
Organovo Holdings, Inc.  10.44 $ 62.751  Millions$ 6.011  Millions
Intellia Therapeutics, Inc.  10.34 $ 257.551  Millions$ 24.910  Millions
Repligen Corp  10.32 $ 141.843  Millions$ 13.751  Millions
Adaptimmune Therapeutics Plc  10.15 $ 170.559  Millions$ 16.802  Millions


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com